Detalhe da pesquisa
1.
Eluxadoline for Irritable Bowel Syndrome with Diarrhea.
N Engl J Med
; 374(3): 242-53, 2016 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26789872
2.
Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea.
Clin Gastroenterol Hepatol
; 15(7): 1021-1029.e6, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28167156
3.
Corrigendum: Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use.
Am J Gastroenterol
; 112(7): 1210, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28555632
4.
Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea.
Am J Gastroenterol
; 112(2): 365-374, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27922029
5.
Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use.
Am J Gastroenterol
; 112(6): 924-932, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28417992
6.
Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
Gastroenterology
; 145(2): 329-38.e1, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23583433
7.
Response to Lai.
Am J Gastroenterol
; 114(7): 1177-1178, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31205133
8.
Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients.
Health Qual Life Outcomes
; 11: 208, 2013 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24330412
9.
Safety of Eluxadoline in Patients With IBS-D Without a Gallbladder.
Am J Gastroenterol
; 112(10): 1619-1620, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28978951
10.
Response to Croteau and Barkin.
Am J Gastroenterol
; 112(10): 1617, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28978962
11.
Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infection.
Antimicrob Agents Chemother
; 55(12): 5790-7, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21947389
12.
Effects of treatment with eluxadoline on abdominal pain in patients with IBS-D: Additional post hoc analyses of Phase 3 trials.
Neurogastroenterol Motil
; 32(4): e13774, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31984655
13.
Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials.
Therap Adv Gastroenterol
; 12: 1756284819841290, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31019552
14.
A Phase 2 study of the novel fluoroquinolone JNJ-Q2 in community-acquired bacterial pneumonia.
J Antimicrob Chemother
; 68(11): 2691-3, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23749951
15.
Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: a randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes.
Clin Ther
; 30(3): 499-512, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18405788
16.
Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects.
Clin Ther
; 30(3): 513-27, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18405789
17.
Evaluation of Eluxadoline Effect on Cardiac Repolarization.
Clin Pharmacol Drug Dev
; 7(7): 727-736, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29659201
18.
Sphincter of Oddi Function and Risk Factors for Dysfunction.
Front Nutr
; 4: 1, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28194398
19.
Effect of uptake transporters OAT3 and OATP1B1 and efflux transporter MRP2 on the pharmacokinetics of eluxadoline.
J Clin Pharmacol
; 55(5): 534-42, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25491493
20.
Item-level assessment of the irritable bowel syndrome quality of life questionnaire in patients with diarrheal irritable bowel syndrome.
Clin Ther
; 36(5): 663-79, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24813429